Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis - Wikidata - awgldk - TriplyDB

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q27025272

about

Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis 25 Years Old Women With Inflammatory Low Back Pain.Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era.High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab.Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma.Maintenance therapy following induction chemoimmunotherapy in patients with diffuse large B-cell lymphoma: current perspective.

P2860

Q36326867-E9AB20D9-1B58-43DD-A2C8-943687CFF652 Q37229557-4300729E-4025-45D5-B8B0-24D7DBFB010B Q37487600-B12D9415-7157-4463-8D9A-F0F6EC1DB797 Q41245405-4D679EE4-9A1C-483D-82CB-3566C323DA32 Q47168459-CB8C3F60-1AA7-4470-8588-EC6F6C3AE730 Q50089372-BB375356-E690-421C-8519-2E1B8B047B83

P2860

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q27025272

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Rituximab treatment strategy f ...... matic review and meta-analysis

@ast

Rituximab treatment strategy f ...... matic review and meta-analysis

@en

Rituximab treatment strategy f ...... matic review and meta-analysis

@nl

type

label

Rituximab treatment strategy f ...... matic review and meta-analysis

@ast

Rituximab treatment strategy f ...... matic review and meta-analysis

@en

Rituximab treatment strategy f ...... matic review and meta-analysis

@nl

prefLabel

Rituximab treatment strategy f ...... matic review and meta-analysis

@ast

Rituximab treatment strategy f ...... matic review and meta-analysis

@en

Rituximab treatment strategy f ...... matic review and meta-analysis

@nl

P1433

Q27025272-0002D671-6073-40D0-B938-B27147571C7F

P1476

Q27025272-DE9EB0DC-48A2-4BF1-AFE5-0DFB9B1FB96A

P2093

Q27025272-2D75C734-9C3D-4149-B191-E010A7FDA419

Q27025272-960F9A95-AAD3-4F80-8631-826D2C3CC942

Q27025272-D1CB493D-CFC7-4015-9B41-B39FF127AC7D

Q27025272-D1CDA77A-502A-4E08-8F0C-1C947076C91F

Q27025272-E86C6D86-C68D-4AFD-AEAE-64251CD79214

P275

Q27025272-9A5F7521-CE18-456E-BF8D-D3DC2F328F82

P2860

Q27025272-229F03F5-8D8F-4444-B7D4-B55D5A329E4E

Q27025272-4930F63D-41C3-414C-BE0E-3F8E9688B93A

Q27025272-56477602-E725-47A9-A565-DF6A3D38FDA9

Q27025272-7149CB67-09BF-4821-B5AD-625020B1FC0E

Q27025272-7E9BFF7E-56B7-40F3-8149-4C9690141EED

Q27025272-88B3787F-6FBB-4D2D-A823-DF8DBE17E69E

Q27025272-8B102311-BD4C-400A-B9E1-B39C6335DDCE

Q27025272-8F9B796B-F728-4481-AE40-7F2067F63AD2

Q27025272-985167CF-0DF8-424F-BA9E-99C311D87E80

Q27025272-98A8A7F1-D983-4C24-93D2-6FB4BB8A36A0

P304

Q27025272-1AD947E8-EB75-477D-B901-01417E872C01

P31

Q27025272-09785E1B-0479-42E3-9DCD-60BC1E0418BE

Q27025272-0CD3CA39-39A8-4917-88EB-56FC9F1AD139

Q27025272-90F0F359-B96C-4568-9974-7F30AB632FAF

Q27025272-AAB650F0-9E66-4E48-8B28-C3BF83566053

P3181

Q27025272-EE3FE1E7-926A-4FA0-8B31-9D1A66826433

P356

Q27025272-2C9A3FCE-13F2-4F50-B68F-A2456DADB255

P407

Q27025272-1F4B4CF3-728A-4B2D-957A-D11B040065F5

P433

Q27025272-47E48BE9-2AD6-40F2-8643-BC25EA406B0B

P478

Q27025272-7CF5E133-62F1-47A9-848E-D285B481DC67

P5008

Q27025272-0E27408B-6241-4CAE-921E-593A33DD4728

P577

Q27025272-797C2551-A817-4FCE-9180-41893B85A78F

P698

Q27025272-F0E30235-C64B-4189-9B26-48D1277FFA35

P921

Q27025272-8E760902-8FF7-45FC-A3A0-60B37A5393F6

Q27025272-90825477-B293-4EF5-B7EA-8A2DDBECB179

Q27025272-DAE95F52-44A1-4F59-BED6-94C4EEF15697

Q27025272-EA358515-38F6-4DAA-A0AD-6A637681A5AD

P932

Q27025272-75AB2BD1-53F0-4754-80B4-A1132109FC7B

P3181

P356

0366-6999.150111

P1433

Chinese Medical Journal

P1476

Rituximab treatment strategy f ...... matic review and meta-analysis

@en

P2093

Li Li

http://www.w3.org/2001/XMLSchema#string

Ping Wu

http://www.w3.org/2001/XMLSchema#string

Yong-Dong Jin

http://www.w3.org/2001/XMLSchema#string

Yuan-Rong Ren

http://www.w3.org/2001/XMLSchema#string

Zhi-Hui Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma.

Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews.

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Maintenance therapy with continuous or switch strategy in advanced non-small cell lung cancer: a systematic review and meta-analysis.

Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphoma.

P304

378-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

1525225

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/0366-6999.150111

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25635435

http://www.w3.org/2001/XMLSchema#string

P921

diffuse large B-cell lymphoma

monoclonal antibody

P932

4837870

http://www.w3.org/2001/XMLSchema#string